These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

731 related items for PubMed ID: 36126785

  • 21. Spray dried lipid nanoparticle formulations enable intratracheal delivery of mRNA.
    Friis KP, Gracin S, Oag S, Leijon A, Sand E, Lindberg B, Lázaro-Ibáñez E, Lindqvist J, Whitehead KA, Bak A.
    J Control Release; 2023 Nov; 363():389-401. PubMed ID: 37741463
    [Abstract] [Full Text] [Related]

  • 22. Spray freeze drying for dry powder inhalation of nanoparticles.
    Ali ME, Lamprecht A.
    Eur J Pharm Biopharm; 2014 Aug; 87(3):510-7. PubMed ID: 24657824
    [Abstract] [Full Text] [Related]

  • 23. Inhalable microparticle platform based on a novel shell-forming lipid excipient and its feasibility for respirable delivery of biologics.
    Wang H, Connaughton P, Lachacz K, Carrigy N, Ordoubadi M, Lechuga-Ballesteros D, Vehring R.
    Eur J Pharm Biopharm; 2022 Aug; 177():308-322. PubMed ID: 35905804
    [Abstract] [Full Text] [Related]

  • 24. Inhalable dry powder formulations of siRNA and pH-responsive peptides with antiviral activity against H1N1 influenza virus.
    Liang W, Chow MY, Lau PN, Zhou QT, Kwok PC, Leung GP, Mason AJ, Chan HK, Poon LL, Lam JK.
    Mol Pharm; 2015 Mar 02; 12(3):910-21. PubMed ID: 25599953
    [Abstract] [Full Text] [Related]

  • 25. Inhalable Nanoparticles/Microparticles of an AMPK and Nrf2 Activator for Targeted Pulmonary Drug Delivery as Dry Powder Inhalers.
    Acosta MF, Abrahamson MD, Encinas-Basurto D, Fineman JR, Black SM, Mansour HM.
    AAPS J; 2020 Nov 16; 23(1):2. PubMed ID: 33200330
    [Abstract] [Full Text] [Related]

  • 26. Characterization and aerosol dispersion performance of advanced spray-dried chemotherapeutic PEGylated phospholipid particles for dry powder inhalation delivery in lung cancer.
    Meenach SA, Anderson KW, Zach Hilt J, McGarry RC, Mansour HM.
    Eur J Pharm Sci; 2013 Jul 16; 49(4):699-711. PubMed ID: 23707466
    [Abstract] [Full Text] [Related]

  • 27. Feasibility of spray drying bacteriophages into respirable powders to combat pulmonary bacterial infections.
    Vandenheuvel D, Singh A, Vandersteegen K, Klumpp J, Lavigne R, Van den Mooter G.
    Eur J Pharm Biopharm; 2013 Aug 16; 84(3):578-82. PubMed ID: 23353012
    [Abstract] [Full Text] [Related]

  • 28. Advanced spray-dried design, physicochemical characterization, and aerosol dispersion performance of vancomycin and clarithromycin multifunctional controlled release particles for targeted respiratory delivery as dry powder inhalation aerosols.
    Park CW, Li X, Vogt FG, Hayes D, Zwischenberger JB, Park ES, Mansour HM.
    Int J Pharm; 2013 Oct 15; 455(1-2):374-92. PubMed ID: 23820131
    [Abstract] [Full Text] [Related]

  • 29. Advanced spray dried proliposomes of amphotericin B lung surfactant-mimic phospholipid microparticles/nanoparticles as dry powder inhalers for targeted pulmonary drug delivery.
    Gomez AI, Acosta MF, Muralidharan P, Yuan JX, Black SM, Hayes D, Mansour HM.
    Pulm Pharmacol Ther; 2020 Oct 15; 64():101975. PubMed ID: 33137515
    [Abstract] [Full Text] [Related]

  • 30. Leucine improves the aerosol performance of dry powder inhaler formulations of siRNA-loaded nanoparticles.
    Xu Y, Harinck L, Lokras AG, Gerde P, Selg E, Sjöberg CO, Franzyk H, Thakur A, Foged C.
    Int J Pharm; 2022 Jun 10; 621():121758. PubMed ID: 35483619
    [Abstract] [Full Text] [Related]

  • 31. Spray-Dried Inhalable Powder Formulations of Therapeutic Proteins and Peptides.
    Eedara BB, Alabsi W, Encinas-Basurto D, Polt R, Mansour HM.
    AAPS PharmSciTech; 2021 Jun 18; 22(5):185. PubMed ID: 34143327
    [Abstract] [Full Text] [Related]

  • 32. Spray-Dried PulmoSphere™ Formulations for Inhalation Comprising Crystalline Drug Particles.
    Weers JG, Miller DP, Tarara TE.
    AAPS PharmSciTech; 2019 Feb 07; 20(3):103. PubMed ID: 30734187
    [Abstract] [Full Text] [Related]

  • 33. Spray-dried powders enhance vaginal siRNA delivery by potentially modulating the mucus molecular sieve structure.
    Wu N, Zhang X, Li F, Zhang T, Gan Y, Li J.
    Int J Nanomedicine; 2015 Feb 07; 10():5383-96. PubMed ID: 26347257
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Comparison of l-Carnitine and l-Carnitine HCL salt for targeted lung treatment of pulmonary hypertension (PH) as inhalation aerosols: Design, comprehensive characterization, in vitro 2D/3D cell cultures, and in vivo MCT-Rat model of PH.
    Acosta MF, Muralidhran P, Abrahamson MD, Grijalva CL, Carver M, Tang H, Klinger C, Fineman JR, Black SM, Mansour HM.
    Pulm Pharmacol Ther; 2020 Dec 07; 65():101998. PubMed ID: 33556627
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Lipid-based particle engineering via spray-drying for targeted delivery of antibiotics to the lung.
    Corzo C, Crvenjak D, Sotirov K, Afonso Urich J, Öhlinger K, Meindl C, Lochmann D, Reyer S, Fröhlich E, Zimmer A, Salar-Behzadi S.
    Int J Pharm; 2023 Jul 25; 642():123201. PubMed ID: 37406948
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 37.